Kenvue Equity

What does Kenvue do? Kenvue Inc. generates revenue through its three business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment sells products like Tylenol for pain care, Zyrtec for allergies, and Nicorette for smoking cessation. The Skin Health and Beauty segment offers Neutrogena face and body care, Listerine for oral hygiene, and Aveeno for skin health. Essential Health includes Johnson’s baby care, Band-Aid for wound care, and oral care products. These brands target consumers globally across 165 countries, with distribution via 114 centers and 38 customer service hubs. Kenvue’s differentiated brand portfolio drives sales, with Tylenol, Neutrogena, and Listerine as key products. The Self Care segment focuses on cough, cold, and allergy remedies, while Skin Health and Beauty emphasizes face and body care. Essential Health covers oral care, baby care, and women’s health products. The company serves consumers directly through retail channels in all regions, leveraging its global distribution network. The company’s revenue streams come from selling its branded products in self-care, skin health, and essential health categories. Tylenol leads in pain care, Neutrogena dominates face and body care, and Johnson’s is prominent in baby care. Brands like Listerine and Aveeno cater to oral and skin health needs, while Band-Aid addresses wound care. Sales occur across 165 countries through 114 distribution centers and 38 customer service centers. Kenvue is one of the most popular companies on Eulerpool.